ID   OC3
AC   CVCL_D859
SY   OC-3; Oral carcinoma 3
DR   BTO; BTO_0004006
DR   ABM; T8327
DR   GEO; GSM950305
DR   GEO; GSM950306
DR   GEO; GSM950307
DR   GEO; GSM950308
DR   Wikidata; Q54931728
RX   DOI=10.1016/j.bgm.2013.07.007;
RX   PubMed=14720193;
CC   Population: Chinese; Taiwan.
CC   Doubling time: 16 hours (Note=At 8th passage) (PubMed=14720193); 24 hours (ABM=T8327).
CC   Omics: Transcriptomics; Microarray.
CC   Donor information: Established from a long term betel leaf chewer non smoker patient (PubMed=14720193).
CC   Derived from site: In situ; Oral cavity, buccal mucosa; UBERON=UBERON_0006956.
ST   Source(s): ABM=T8327
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D12S391: 18,21
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D18S51: 16
ST   D19S433: 13,16
ST   D1S1656: 17.3
ST   D21S11: 30,31.2
ST   D2S1338: 21,22
ST   D2S441: 11,12
ST   D3S1358: 15,16
ST   D5S818: 11,12
ST   D7S820: 9,11
ST   D8S1179: 13
ST   FGA: 24,25.2
ST   Penta D: 9,12
ST   Penta E: 11,17
ST   TH01: 7,10
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C4040; Buccal mucosa squamous cell carcinoma
DI   ORDO; Orphanet_502363; Squamous cell carcinoma of the oral cavity
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   57Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 10-04-25; Version: 14
//
RX   DOI=10.1016/j.bgm.2013.07.007;
RA   Wang S.-H., Chou H.-C.;
RT   "Migratory activity and invadosome formation in invasive oral cancer
RT   cells.";
RL   Biomarkers Genomic Med. 5:79-83(2013).
//
RX   PubMed=14720193; DOI=10.1111/j.1600-0714.2004.00034.x;
RA   Lin S.-C., Liu C.-J., Chiu C.-P., Chang S.-M., Lu S.-Y., Chen Y.-J.;
RT   "Establishment of OC3 oral carcinoma cell line and identification of
RT   NF-kappa B activation responses to areca nut extract.";
RL   J. Oral Pathol. Med. 33:79-86(2004).
//